Key PointsEli Lilly still has a large addressable market in the anti-obesity space.The company boasts a deep pipeline of assets within and outside of its core therapeutic areas.Eli Lilly is an attractive dividend stock. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) has been firing on all cylinders. The stock is up 40% over the past 12 months as the company continues to grow revenue and earnings faster than most of its similarly…